The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 

 

This Article
-Abstract
-Full Text

Supplement to Zhang L et al. Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer. N Engl J Med 2003;348:203-13.

Supplementary Appendixes


View Table
Supplementary Appendix 1. Antibodies Used for Immunostaining.

 

View Table
Supplementary Appendix 2. Tests Performed on Tumor Specimens.*

 

View Table
Supplementary Appendix 3. Amplification Primers Used for Real-Time Quantitative Polymerase Chain Reaction.

 

View Figure
Supplementary Appendix 4. Activation of Immune Mechanisms in Association with Intratumoral T Cells.

In Panel A, double immunofluorescence with a monoclonal antibody against CD83 (Texas red; red, arrows) and with a polyclonal antibody against CD3 (fluorescein; green) demonstrates clustering of T cells around a CD83+ antigen-presenting cell. The inset shows immunohistochemical detection of a CD83+ cell with morphologic features of a dendritic cell, surrounded by small mononuclear cells with scant cytoplasm, identifying them as lymphocytes. Panel B shows quantification by image analysis of CD83+ cells detected by immunohistochemical analysis in tumors with T cells and those without T cells. There is a significantly higher number of CD83+ cells in tumors harboring T cells than in tumors without T cells. In Panel C, double immunofluorescence with a monoclonal antibody against CD45RO (Texas red; red) and a polyclonal antibody against CD3 (fluorescein; green) shows memory CD45RO+CD3+ T cells in a tumor containing T cells. Double-positive cells appear yellow due to colocalization of both CD45RO and CD3 on the cell surface. Panel D shows quantification by image analysis of CD45RO+ (memory) T cells detected by immunohistochemical analysis in the stroma of tumors with or without T cells. There are significantly more memory T cells in the stroma of tumors containing T cells than in the stroma of tumors without T cells. In Panel E, double immunofluorescence with a monoclonal antibody against CD3 (fluorescein; green) and a polyclonal antibody against Ki-67 (Texas red; red) reveals activated Ki-67+CD3+ T cells in a tumor containing T cells. Panel F shows the results of real-time quantitative PCR analysis of the levels of interleukin-2 and interferon-gamma messenger RNA (mRNA) in 16 ovarian carcinomas harboring intratumoral T cells and 10 ovarian carcinomas without intratumoral T cells. Higher levels of interleukin-2 mRNA (P=0.09) and interferon-gamma mRNA (P=0.02) were found in tumors containing T cells than in tumors without T cells. The presence of both cytokines indicates antigen-dependent T-cell activation and type 1 polarization. The y axis represents the relative expression of interferon-gamma and interleukin-2 in relation to glyceraldehyde-3-phosphate dehydrogenase.

 

 

This Article
-Abstract
-Full Text


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.